← Open Payments lookup

CHASE JACOMINI: Open Payments

NPI 1053960385 · FRAMINGHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$223 in 10 payments from 7 companies in 2025. Trend: 2023 $95 · 2024 $714 · 2025 $223

Food & beverage: $223
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$51
E.R. Squibb & Sons, L.L.C.2$49
Alkermes, Inc.2$37
Axsome Therapeutics, Inc.1$30
Otsuka America Pharmaceutical, Inc.1$21
Neurocrine BioSciences, Inc.1$20
Lundbeck LLC1$15

Products named: CAPLYTA, COBENFY, REXULTI, Auvelity, ARISTADA, INGREZZA, LYBALVI.

Industry payments across MA — which companies pay providers there.